We found that the targets of nifedipine, such as voltage-dependent L-type calcium channel subunit alpha-1C (CACNA1C), subunit alpha-1D (CACNA1D) and beta-2 (CACNB2), have important links to cancer development and progression45–49. This evidence concerns the gene CACNA1D and cancer.